*

Penny Stock DD

Featured Companies


UV Flu Technologies Inc. (OTCBB: UVFT.OB) develops highly innovative air purification technology that purifies indoor air by killing airborne bacteria. The Company’s flagship product, ViraTechTM UV-400 model, utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtering to destroy harmful bacteria. Extensive independent testing by EPA and FDA certified laboratories confirms the proprietary system kills airborne bacteria at rates exceeding 99.2% on a first-pass basis.

Increased media attention and growing public concern over the rise of the H1N1 swine flu pandemic, antibiotic resistant superbugs, asthma, allergies, tuberculosis, Sick Building Syndrome and toxic mold are spurring governments, employers and homeowners to take action to safeguard their health.

UV Flu’s proven air purification technology uses high-intensity ultraviolet light (UV-C) to clean air and destroy bacteria. Its flagship ViraTechTM UV-400 product draws air in through a killing chamber cartridge where baffles provide the turbulence necessary to bring bacteria in close proximity to the special UVC lamps, allowing the germicidal UV-C to kill any bacteria present. Before exiting, the air stream passes through a gross particulate screen which removes the neutralized dust and debris. The sealed cartridge can be discarded with regular trash after 12 months of continuous operation. This is an advantage over HEPA filter products which trap but do not kill the bacteria, requiring filters to be discarded as red bag waste.

The ViraTech UV-400 unit has been laboratory tested with proven results in reducing odors and VOC’s (volatile organic compounds). Independent EPA and FDA certified laboratory testing confirms the system kills airborne bacteria at rates ranging from 99.2% to more than 99.99% on a first-pass basis. In actual operation multiple passes through the unit will occur, producing average removal rates that far exceed 99.2%.

The Company has completed the design of its second product, a smaller, lower cost version of the ViraTechTM UV-400. UV Flu expects to begin shipping the new model into commercial accounts before the end of 2010. Additional products will follow.

What Sets UV Flu Apart

  • Independent lab testing confirming over 99% effectiveness eliminating bacteria.
  • The ViraTech UV-400 unit has been laboratory tested with proven results in reducing odors and VOC’s (volatile organic compounds).
  • U.S. Patent No. 6939397 covering highly innovative air disinfecting technology and product design.
  • Environmentally friendly, energy conscious technology.
  • Third party testing and certification of product as electrically and operationally safe to use, eliminating product liability issues.
  • Unique replaceable cartridge design to provide continuous revenue stream throughout product lifecycle.

For more information on UV Flu Technologies, please go to www.uvflutech.com. For a copy of Analyst’s STRONG BUY Recommendation Report on UVFT, please go to www.biotechstockpick.com.

Happy trading,

Curt

About The Company

Medisafe 1 Technologies Corp., a development stage company, plans to develop a commercial application of the design in a patent titled ‘Protector for administering medicine’, which is a device that prevents errors in administering medications. The company was incorporated in July 2009 and is based in Jerusalem, Israel.

OVERVIEW

Protector device with locking mechanism ensures substance is only released from the hypodermic needle after positive technology-based pre-matching with the specific patient, using barcode or other ID methods.

(Read the Rest of the Article…)

Happy trading,

Curt

NFRM is likely a ticker you have not seen or heard of before.  Since it began trading at the end of August, NFRM has seriously flown under the radar until recently.  At this point, NFRM is literally on the GROUND FLOOR!

NFRM recently announced that it has entered into a Letter of Intent (LOI) to acquire a certain Proprietary Robotic technology from Excelco Systems International. Excelco has developed a multi arm Robotic Technology that can easily do multiple applications at the same time therefore increasing efficiencies of any type of assembly lines or packaged goods manufacturing for Medical, Pharmaceutical, Food and many other industries.

About the Company
We are a biotechnology company with focus on tissue and muscle injury. Injuries to muscle such as back pain or ligaments and vascular injuries such as sclerosis are often permanent and carry significant socioeconomic consequences. About 10 million people in the United States suffer from back muscle injuries that have become a chronic back pain. Another 2-3 million suffer from sport related injuries, ligaments stretched, spasm etc. These conditions carries a life time pain, that can not be resolved by normal and usual pain killers. Pain and suffering from these injuries are due to the constant release of chemical mediators, known as cytokines. We have discovered molecules, known as growth factors that prevent the effect of these cytokines and associated pain by preventing further damage to the tissue and rebuilding the damaged tissues.

Happy trading,

Curt

About the Company
INCA Designs, Inc. (IDGI.PK) designs, contracts for the manufacture of, and retails collections of resort wear, swimwear and accessories. The INCA brand is sold in the United States, Japan, Mexico, Puerto Rico, and throughout the Caribbean. The Company sells its products through retail stores throughout the world. Retail locations carrying the INCA line include Everything but Water, ShopBop, Swimwear boutique.com, Ritz Carlton Resorts, Kerzner International and Hilton International.

INCA is sold online on its interactive Website and in select online retail boutiques. As of December 31, 2009, the Company had a wholly owned subsidiary: S2 and S2 in turn has two wholly-owned subsidiaries, INCA of South Beach and INCA on LEX.

About the Brand
Inca Designs Inc. designs, sources and sells high fashion designer swimwear, resort wear and accessories for the wholesale and retail markets under the brand name Inca. The Company has also expanded its apparel lines to include children’s fashion with Inca Girl launched in 2005, and is planning a new line of home accessories. This Miami-based swim and resort wear designer currently markets its apparel through several retail boutiques and specialty stores, including Ritz-Carlton, Swimwear Boutique, Beloved Star, 25 Park, and many others. Inca branded apparel is sold in US, Europe, Asia, and the Caribbean. Additionally, Inca is now represented by Salon-9, the wholesale buyer showroom started by Red Carter, in Los Angeles and New York.

Happy trading,

Curt


ADHC .003
Shares Out  271 M
Float  96 M
Market Cap $867 K.

After the Bell Tuesday, Chairman/CEO Ernest B. Remo announced that American Diversified Holdings has set a strategy for software development to create a mobile platform in the electronic health records (EHR) market specifically designed for the Apple(R) iPad(TM). Other mobile platforms, including the Android(TM) developed by Google(R), will also be integrated into the strategy.

American Diversified Holdings Corporation is developing a unique software platform for the Mobile Health Care Market as the medical profession gears up to go electronic for Electronic Health Records (EHR) and also for direct patient monitoring and information.

American Diversified Holdings has contracted with Com-Guard, Inc., a San Diego-based technology firm that has been developing software in the security and data protection markets for more than 10 years, to create this mobile application (press release of Dec 21, 2010).

Apple iPads and Android-powered tablets are expected to have explosive growth in 2011, and expecting Microsoft Windows-related tablets likely to be entering the marketplace as well.

Happy trading,

Curt

More on this topic (What's this?)
Guards Go Robotic in a South Korean Prison
Update on Sonata Software
UFile Tax Software Giveaway
Read more on Computer Software, Holdings at Wikinvest


Title Consulting Services, Inc. specializes in closing real estate sales transactions, reverse mortgages and refinances.

Title Consulting Services, Inc. (OTC.PK: TITL)

Whether looking to buy, sell or refinance a mortgage, or just have a title insurance related question, Accu Title Agency can help.

Accu Title Agency is a publicly traded Title Insurance company trading under the name Title Consulting Services, Inc. Accu Title Agency is the seventh largest Title Insurance company in the state of Florida.

Headquartered in St. Petersburg, Florida, Accu Title Agency has been providing title insurance and real estate closing services as an independent title insurance agency since 2001. They offer a network of strategically placed locations across the state of Florida, such that very few homes would be more than an hour’s drive from one of their offices. They have over 40 closers on staff ready to suit all closing needs. They generally offer a 24 to 48 hour turnaround on commitments.  Their highly experienced policy department ensures timely delivery of final title policies.

Accu Title Agency stands ready and capable of handling all closings in an expeditious and professional manner.

Happy trading,

Curt

GOSY – GeckoSystems Intl. Corp. has been around a long time, but has much potential if the Company can indeed secure the necessary financing to move forward . GOSY has come a long way from the days when it was an idea, and if you review the long list of PR’s from the Company, you can see that they have made great strides in the last number of months since the beginning of Home Trials with the CareBot.

About GeckoSystems:
Since 1997, GeckoSystems has developed a comprehensive, coherent, and sufficient suite of hardware and software inventions to enable a new type of home appliance (a personal robot) the CareBot, to be created for the mass consumer marketplace. The suite of primary inventions includes: GeckoNav, GeckoChat and GeckoTrak.

The primary market for this product is the family for use in eldercare, care for the chronically ill, and childcare. The primary distribution channel for this new home appliance is the thousands of independent personal computer retailers in the U.S. The manufacturing infrastructure for this new product category of mobile service robots is essentially the same as the personal computer industry. Several outside contract manufacturers have been identified and qualified their ability to produce up to 1,000 CareBots per month within four to six months.

Happy trading,

Curt

More on this topic (What's this?) Read more on Inter-Tel at Wikinvest

Power3 Medical Products, Inc. (PWRM.OB) is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. This dynamic team utilizes proteomics in the discovery of protein biomarkers, drug pathways, and mechanisms of disease.

PWRM strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies, world class quality procedures and superior research methodologies. The Company will be guided in all of its dealings with its customers, partners, shareholders, associates and investors by the philosophy of best practices.

Power3 Medical Products, Inc. plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into PWRM, with PWRM remaining as the surviving company in the merger.

(Read the Rest of the Article…)

Happy trading,

Curt


UV Flu Technologies, Inc., a development stage company, engages in the research, development, manufacture, and sale of air purification systems and products. The company focuses on producing and distributing the UV 400 Viraguard, which utilizes high-intensity germicidal ultraviolet radiation inside a killing chamber that destroys airborne bacteria, deactivates allergens, viruses, spores, and mold. It intends to sell its products directly or through distributors to medical accounts, including hospitals, doctor and dentist offices, clinics, and nursing homes.

Visit their Website!

Now is The Time To Buy Shares in UVFT for just pennies on the dollar. Based on everything known about UVFT, 370% gains over the coming weeks is just the beginning!

UVFT (OTCQB) – I’d urge you to take a few minutes to learn more about this company, and further investigate its prospects. Bacterial infections acquired during hospital stays are so widespread that 26 states have enacted laws requiring hospitals to report their infection rates.

Using UVFT’s FDA-approved Viratech UV-400, hospitals can begin obliterating bacteria and airborne pathogens on-the-spot with a 99% kill rate on every pass through.

Put it altogether and think of the potential for UVFT’s technology to revolutionize the industry. Influenza, bacterial infections, chronic respiratory diseases – the market for UVFT technology is mind boggling.

UVFT Management Comes From Some of the Biggest Moneymakers in Health Care and Finance.

Although UVFT’s flagship product is just launching, this leading young biotech already has substantial orders from various key market sectors.

Organizations like the well-respected Massachusetts General Hospital (Harvard’s teaching hospital and Top 5 Hospital in USA), New England Baptist Hospital and New England Sports Sales, a major specialty sporting equipment distributor, have placed orders.

Happy trading,

Curt

Performance Optimization WordPress Plugins by W3 EDGE